Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Viatris in the Drug Discovery & Development Pharma 50

Viatris

Rank: 24

2021 Rank: 22

Canonsburg, Pennsylvania, United States
www.viatris.com

2021 Revenues ($USD) : $17,813,600,000
2021 R&D spend : $751,100,000
2021 Number of Employees : 37,000
Fiscal Year End : 12/31/2021
Leader : CEO Michael Goettler

Created in 2020 as the merger of Mylan and Pfizer’s Upjohn unit, Viatris has a lineup of well-known off-patent drugs such as Viagra, Xanax and Lipitor — as well as other generics, over-the-counter drugs and active pharmaceutical ingredients. The company also had a variety of biosimilars, but is offloading them to Biocon Biologics in a transaction worth up to $3.34 billion. —BB

Viatris

[Viatris is one of the world’s largest producers of APIs. Image courtesy of Viatris.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50